Virax Biolabs Group Ltd (VRAX) Operating cash flow 2021–2025
Virax Biolabs Group Ltd (VRAX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.6MFY2025 · since FY2021: -$590,186 → -$4.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.6M | +26.9% |
| FY2024 | -$6.2M | -49.5% |
| FY2023 | -$4.2M | -416.6% |
| FY2022 | -$809,070 | -37.1% |
| FY2021 | -$590,186 | — |
Source: SEC XBRL filings · For reference only · Not investment advice